---
title: 177-Lu-lilotomab satetraxetan
date: 2023-10-26
external_link: 
tags:
  - lymphoma
  - dosimetry
  - theragnostics
---

Absorbed dose calculations for a phase 1/2a trial of indolent lymphoma patients treated with the antibody radionuclide conjugate therapy 177-Lu-lilotomab satetraxetan.

<!--more-->
